"NeoGenomics Inc. (NGNM) said it expects first quarter results to range from breakeven to earnings of $0.01 per share on revenue of $13.5 million to $14.0 million. There are no current estimates for the quarter ending March 31, 2012. The company said it expects 2012 earnings of $0.02 to $0.04 per share on revenue of $54.0 million to $59.0 million. The current consensus earnings estimate is $0.03 per share on revenue of $51.7 million for the year ending December 31, 2012." Unless of course CMS finally catches on to their TC/PC products. Unless the TC/PC billing laws change....which they will... etc, etc, etc,,,,,,, That is why I left years ago....
Oh yeah a-hole!! http://www.darkdaily.com/in-fixing-physician-medicare-pay-congress-enacts-yet-another-cut-in-clinical-laboratory-test-fee-schedule-022012#axzz1myh3Y7nH Read the Dark Report and WEEEEEPPPPP!!!
Hey it is already May!! Where are the 25 new Molecular Assays your reps keep telling my clients your coming out with??
our launch was so fast you missed it. We now plan to launch one new test every week until someone passes out, then one every other week.
